Personal profile
Headline
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Baseline absolute lymphocyte count, C-reactive protein, and ferritin predict CAR T cell-related toxicities and outcomes in multiple myeloma
Pan, D., Mouhieddine, T. H., Sheng, T., Fu, W., Moshier, E., Richter, J., Parekh, S., Jagannath, S., Chari, A., Rossi, A. C., Sanchez, L. J., Thibaud, S., Rodriguez, C., Cho, H. J. & Richard, S., May 2026, In: Bone Marrow Transplantation. 61, 5, p. 639-641 3 p.Research output: Contribution to journal › Letter › peer-review
-
Comment on “how the addition of selinexor/bortezomib/dexamethasone as a Category 1 recommendation may erode outcomes”
Richter, J., Davis, M. & Chai, Y., May 2026, In: Oncologist. 31, 5Research output: Contribution to journal › Letter › peer-review
Open Access -
Dual Targeting of Extramedullary Myeloma with Talquetamab and Teclistamab
Kumar, S., Mateos, M. V., Ye, J. C., Atrash, S., Magen, H., Quach, H., Chu, M. P., Trudel, S., Richter, J., Rodríguez-Otero, P., Chuah, H., Gatt, M., Medvedova, E., Raza, S., Yoon, D. H., Ishida, T., Matous, J. V., Rosiñol, L., Onodera, K. & Scott, E. & 15 others, , 1 Jan 2026, In: New England Journal of Medicine. 394, 1, p. 51-61 11 p.Research output: Contribution to journal › Article › peer-review
12 Scopus citations -
Efficacy and Safety of Talquetamab + Teclistamab in Patients with Relapsed/Refractory Multiple Myeloma and Extramedullary Disease: Updated Phase 2 Results From The Redirectt-1 Study with Extended Follow-Up
Mateos, M. V., Rodríguez-Otero, P., Usmani, S. Z., Kumar, S., Ye, J. C., Atrash, S., Cohen, Y. C., Magen, H., Quach, H., Chu, M. P., Trudel, S., Richter, J., Chuah, H., Gatt, M., Medvedova, E., Raza, S., Yoon, D. H., Ishida, T., Matous, J. V. & Rosiñol, L. & 15 others, , 2026, In: Haematologica. 111, s2, p. 1 1 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Extramedullary Disease—Achilles Heel in Myeloma?
Kumar, S., Richter, J., Usmani, S. Z., Cohen, Y. C., Ye, J. C., Mateos, M. V., Hungria, V. & Zamagni, E., Mar 2026, In: American Journal of Hematology. 101, 3, p. 521-536 16 p.Research output: Contribution to journal › Review article › peer-review
Open Access1 Scopus citations
Press/Media
-
Mount Sinai Researchers to Present Expansive Range of Cancer Research at 2026 ASCO Annual Meeting
Hirsch, F., Hirsch, F., Richter, J., Galsky, M., Parsons, R., Marron, T., van Gerwen, M., Mascarenhas, J. & Roof, S.
27/05/26 → 28/05/26
4 items of Media coverage
Press/Media
-
Recent Findings from Icahn School of Medicine at Mount Sinai Advance Knowledge in Multiple Myeloma (Effect of intravenous immunoglobulin on infections in multiple myeloma patients receiving daratumumab)
Moshier, E., Sastow , D., Richter, J., Lancman, G., Parekh, S., Jagannath, S., Chari, A., Cho, H. & Rodriguez, C.
30/04/26
1 item of Media coverage
Press/Media
-
Researchers' Work from Icahn School of Medicine at Mount Sinai Focuses on Hematopoiesis (Clonal Hematopoiesis and Inflammation Predict Hematologic Toxicity and Secondary Myeloid Malignancies after B-Cell Maturation Antigen-Directed Chimeric ...)
Moshier, E., Richter, J., Cho, H. & Rodriguez, C.
23/10/25
1 item of Media coverage
Press/Media
-
New REDUCE-IT® Analyses Presented at ESC 2025 Include Data Showing VASCEPA®/VAZKEPA® (Icosapent Ethyl) Therapy Resulted in 9% Fewer Total...
30/08/25
9 items of Media coverage
Press/Media